Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 1 1 1 136
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 0 0 48
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 1 2 3 122
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 0 0 2 154 2 2 12 395
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 0 1 6 676
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 0 43 0 0 3 159
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 16 16 0 3 36 36
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 1 22 0 3 12 51
Optimizing Tax Administration Policies with Machine Learning 1 1 2 266 5 8 12 697
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 1 1 4 198
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 0 0 2 24 1 4 8 70
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 0 0 1 130
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 1 89 2 2 4 130
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 0 1 3 91
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 0 3 7 123
What exactly is public in a public good game? A lab-in-the-field experiment 0 0 2 156 2 4 12 368
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 3 95 1 2 12 155
Total Working Papers 1 1 29 1,463 16 37 136 3,585


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 2 17 1 1 5 88
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 1 3 6 37
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 2 2 2 17
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 0 1 2 23
Machine learning and the optimization of prediction-based policies 0 0 1 5 2 4 12 21
R&D and market size: Who benefits from orphan drug legislation? 0 0 0 4 0 1 5 32
R&D investments, financing constraints, exporting and productivity 0 0 1 57 0 0 4 166
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 1 1 3 20 1 1 8 115
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 0 0 0 2 1 1 1 8
The impact of managed entry agreements on pharmaceutical prices 0 1 3 16 0 1 11 83
The impact of social pressure on tax compliance: A field experiment 0 0 2 26 0 0 9 127
When the two ends meet: an experiment on cooperation and social capital 0 1 1 6 1 3 5 31
Total Journal Articles 1 3 13 166 9 18 70 748


Statistics updated 2025-11-08